Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential.
Kneppers J, Severson TM, Siefert JC, Schol P, Joosten SEP, Yu IPL, Huang CF, Morova T, Altıntaş UB, Giambartolomei C, Seo JH, Baca SC, Carneiro I, Emberly E, Pasaniuc B, Jerónimo C, Henrique R, Freedman ML, Wessels LFA, Lack NA, Bergman AM, Zwart W.
Kneppers J, et al. Among authors: henrique r.
Nat Commun. 2022 Nov 30;13(1):7367. doi: 10.1038/s41467-022-35135-2.
Nat Commun. 2022.
PMID: 36450752
Free PMC article.